
Michael T. Brannock
Examiner (ID: 14930)
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1649, 1646 |
| Total Applications | 341 |
| Issued Applications | 113 |
| Pending Applications | 69 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6856993
[patent_doc_number] => 20030130494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Mammalian chemokine reagents'
[patent_app_type] => new
[patent_app_number] => 10/293050
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17571
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130494.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293050 | Mammalian chemokine reagents | Nov 12, 2002 | Issued |
Array
(
[id] => 642228
[patent_doc_number] => 07122639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Chemokine alpha-2 antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/267900
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 20158
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10267900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/267900 | Chemokine alpha-2 antibodies | Oct 9, 2002 | Issued |
| 10/110668 | G protein-coupled receptors expressed in brain | Oct 2, 2002 | Abandoned |
Array
(
[id] => 6668873
[patent_doc_number] => 20030113857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/245695
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 44991
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113857.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245695 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 16, 2002 | Abandoned |
Array
(
[id] => 6653147
[patent_doc_number] => 20030105316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Regulation of human opsin-related g protein-coupled receptor'
[patent_app_type] => new
[patent_app_number] => 10/221558
[patent_app_country] => US
[patent_app_date] => 2002-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21305
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221558
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221558 | Regulation of human opsin-related g protein-coupled receptor | Sep 12, 2002 | Abandoned |
Array
(
[id] => 634147
[patent_doc_number] => 07129203
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-31
[patent_title] => 'Site specific protein modification'
[patent_app_type] => utility
[patent_app_number] => 10/243230
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7814
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/129/07129203.pdf
[firstpage_image] =>[orig_patent_app_number] => 10243230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/243230 | Site specific protein modification | Sep 11, 2002 | Issued |
Array
(
[id] => 6787664
[patent_doc_number] => 20030138903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/243431
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45006
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138903.pdf
[firstpage_image] =>[orig_patent_app_number] => 10243431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/243431 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 11, 2002 | Abandoned |
Array
(
[id] => 6668340
[patent_doc_number] => 20030113323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Antagonists of HMG1 for treating inflammatory conditions'
[patent_app_type] => new
[patent_app_number] => 10/242056
[patent_app_country] => US
[patent_app_date] => 2002-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8065
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242056 | Antagonists of HMG1 for treating inflammatory conditions | Sep 10, 2002 | Issued |
Array
(
[id] => 6730134
[patent_doc_number] => 20030186324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Sensory neuron receptors'
[patent_app_type] => new
[patent_app_number] => 10/237467
[patent_app_country] => US
[patent_app_date] => 2002-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18354
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237467
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237467 | Sensory neuron receptors | Sep 5, 2002 | Abandoned |
Array
(
[id] => 6774628
[patent_doc_number] => 20030017966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'MC4-R as target for the identification of compounds used to treat drug addiction'
[patent_app_type] => new
[patent_app_number] => 10/226594
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10782
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226594
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226594 | MC4-R as target for the identification of compounds used to treat drug addiction | Aug 22, 2002 | Abandoned |
Array
(
[id] => 6773817
[patent_doc_number] => 20030017155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Antagonists of HMG1 for treating inflammatory conditions'
[patent_app_type] => new
[patent_app_number] => 10/210747
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8066
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017155.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210747 | Antagonists of HMG1 for treating inflammatory conditions | Jul 30, 2002 | Issued |
Array
(
[id] => 725286
[patent_doc_number] => 07045675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-16
[patent_title] => 'Genes for Niemann-Pick type C disease'
[patent_app_type] => utility
[patent_app_number] => 10/208731
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19155
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/045/07045675.pdf
[firstpage_image] =>[orig_patent_app_number] => 10208731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/208731 | Genes for Niemann-Pick type C disease | Jul 28, 2002 | Issued |
Array
(
[id] => 6817793
[patent_doc_number] => 20030068751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/205901
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068751.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205901
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205901 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 25, 2002 | Abandoned |
Array
(
[id] => 6783016
[patent_doc_number] => 20030064463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/206922
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61087
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206922 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 25, 2002 | Abandoned |
Array
(
[id] => 6813632
[patent_doc_number] => 20030073182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/205891
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61092
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205891
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205891 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 24, 2002 | Abandoned |
Array
(
[id] => 6814263
[patent_doc_number] => 20030073813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/205904
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 615
[patent_figures_cnt] => 615
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073813.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205904 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 24, 2002 | Abandoned |
Array
(
[id] => 6778702
[patent_doc_number] => 20030049783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/205909
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61105
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205909
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205909 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 24, 2002 | Abandoned |
Array
(
[id] => 6817783
[patent_doc_number] => 20030068741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/201854
[patent_app_country] => US
[patent_app_date] => 2002-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10201854
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/201854 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 22, 2002 | Abandoned |
Array
(
[id] => 6720781
[patent_doc_number] => 20030054469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/201324
[patent_app_country] => US
[patent_app_date] => 2002-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10201324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/201324 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 21, 2002 | Abandoned |
Array
(
[id] => 6843095
[patent_doc_number] => 20030148442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/199672
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57321
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148442.pdf
[firstpage_image] =>[orig_patent_app_number] => 10199672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/199672 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 17, 2002 | Abandoned |